Effect of Omega-3 supplementation on endothelial function & quality of life in hemodialysis patients
Not Applicable
- Conditions
- End Stage Renal Disease.End Stage Renal Disease
- Registration Number
- IRCT201309242417N13
- Lead Sponsor
- Vice Chancellor for Research, Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1)at least 18 years old. 2)hemodialysis for at least 3 months. 3)consent for cooperation 4) without usage of omega-3 during past 3 months Exclusion criteria: 1)history of steatorrhea. 2) malignancy. 3) abnormal coagulation profile. 4)need for anticoagulation therapy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum ICAM level. Timepoint: at begining and after 6 months. Method of measurement: ELISA kit, µg/mL.;Serum VCAM level. Timepoint: at begining and after 6 months. Method of measurement: ELISA kit, µg/mL.;Quality of life of hemodialysis patients. Timepoint: at begining and after 6 months. Method of measurement: questioneer.
- Secondary Outcome Measures
Name Time Method